Lucía Taja‐Chayeb

2.7k total citations
64 papers, 2.1k citations indexed

About

Lucía Taja‐Chayeb is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lucía Taja‐Chayeb has authored 64 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 19 papers in Cancer Research and 17 papers in Oncology. Recurrent topics in Lucía Taja‐Chayeb's work include Epigenetics and DNA Methylation (21 papers), Histone Deacetylase Inhibitors Research (15 papers) and Cancer Genomics and Diagnostics (7 papers). Lucía Taja‐Chayeb is often cited by papers focused on Epigenetics and DNA Methylation (21 papers), Histone Deacetylase Inhibitors Research (15 papers) and Cancer Genomics and Diagnostics (7 papers). Lucía Taja‐Chayeb collaborates with scholars based in Mexico, United States and Colombia. Lucía Taja‐Chayeb's co-authors include Alfonso Dueñas‐González, Enrique Pérez‐Cárdenas, Catalina Trejo‐Becerril, Alma Chávez‐Blanco, Aurora González‐Fierro, Myrna Candelaria, Blanca Segura-Pacheco, Lucely Cetina, Alma Luísa Revilla Vázquez and Carlos Pérez‐Plasencia and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Lucía Taja‐Chayeb

60 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lucía Taja‐Chayeb Mexico	22	1.5k	358	340	179	168	64	2.1k
Enrique Pérez‐Cárdenas Mexico	23	1.8k 1.1×	389 1.1×	389 1.1×	186 1.0×	221 1.3×	48	2.4k
Catalina Trejo‐Becerril Mexico	18	1.2k 0.8×	311 0.9×	258 0.8×	122 0.7×	147 0.9×	40	1.6k
Aurora González‐Fierro Mexico	21	1.0k 0.7×	233 0.7×	266 0.8×	88 0.5×	123 0.7×	46	1.5k
Hongling Peng China	24	885 0.6×	470 1.3×	404 1.2×	157 0.9×	97 0.6×	117	1.7k
Deborah A. Tweddle United Kingdom	28	1.3k 0.9×	709 2.0×	854 2.5×	182 1.0×	137 0.8×	64	2.2k
Myrna Candelaria Mexico	25	1.4k 0.9×	243 0.7×	563 1.7×	135 0.8×	299 1.8×	88	2.5k
Tatsuro Furui Japan	23	986 0.6×	156 0.4×	323 0.9×	229 1.3×	84 0.5×	110	2.1k
Thomas W. Davis United States	24	1.1k 0.7×	457 1.3×	634 1.9×	189 1.1×	77 0.5×	54	2.0k
Angela Ogden United States	24	1.5k 1.0×	269 0.8×	575 1.7×	120 0.7×	121 0.7×	52	2.3k
Jian‐Qing Mi China	22	1.4k 0.9×	337 0.9×	379 1.1×	142 0.8×	138 0.8×	92	2.1k

Countries citing papers authored by Lucía Taja‐Chayeb

Since Specialization

Citations

This map shows the geographic impact of Lucía Taja‐Chayeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucía Taja‐Chayeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucía Taja‐Chayeb more than expected).

Fields of papers citing papers by Lucía Taja‐Chayeb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucía Taja‐Chayeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucía Taja‐Chayeb. The network helps show where Lucía Taja‐Chayeb may publish in the future.

Co-authorship network of co-authors of Lucía Taja‐Chayeb

This figure shows the co-authorship network connecting the top 25 collaborators of Lucía Taja‐Chayeb. A scholar is included among the top collaborators of Lucía Taja‐Chayeb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucía Taja‐Chayeb. Lucía Taja‐Chayeb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cacho‐Díaz, Bernardo, et al.. (2024). TP53 oncogenic variants as prognostic factors in individuals with glioblastoma: a systematic review and meta-analysis. Frontiers in Neurology. 15. 1490246–1490246.

Dueñas‐González, Alfonso, et al.. (2022). Progress in Metabolic Studies of Gastric Cancer and Therapeutic Implications. Current Cancer Drug Targets. 22(9). 703–716. 7 indexed citations

Díaz‐Chávez, José, et al.. (2022). ctDNA Is Useful to Detect Mutations at Codon 641 of Exon 16 of EZH2, a Biomarker for Relapse in Patients with Diffuse Large B-Cell Lymphoma. Cancers. 14(19). 4650–4650. 2 indexed citations

Lino‐Silva, Leonardo S., Alma Chávez‐Blanco, Guadalupe Domínguez-Gómez, et al.. (2022). Expression of Hexokinase-2 (HK2), Glutaminase-1 (GLS1) Y Fatty Acid Synthase (FASN) in Gastric Cancer and Their Prognostic Significance. SSRN Electronic Journal. 1 indexed citations

Taja‐Chayeb, Lucía, et al.. (2021). Familial erythrocytosis 2 and von Hippel-Lindau disease in the same pediatric patient. Boletín Médico del Hospital Infantil de México. 78(4). 341–345. 2 indexed citations

Taja‐Chayeb, Lucía, Silvia Vidal-Millán, Catalina Trejo‐Becerril, et al.. (2021). Hereditary diffuse gastric cancer (HDGC). An overview. Clinics and Research in Hepatology and Gastroenterology. 46(4). 101820–101820. 12 indexed citations

Pérez‐Cárdenas, Enrique, Lucía Taja‐Chayeb, Catalina Trejo‐Becerril, et al.. (2018). Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells. OncoTargets and Therapy. Volume 11. 8823–8833. 5 indexed citations

Perdomo‐Pantoja, Alexander, Nancy Reynoso‐Noverón, Ernesto Soto‐Reyes, et al.. (2018). Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma. PLoS ONE. 13(11). e0206590–e0206590. 11 indexed citations

Chávez‐Saldaña, Margarita, et al.. (2017). Single nucleotide polymorphisms associated with nonsyndromic cryptorchidism in Mexican patients. Andrologia. 50(1). e12788–e12788. 3 indexed citations

10.

Hidalgo‐Bravo, Alberto, Antonio Miranda‐Duarte, Lucía Taja‐Chayeb, et al.. (2016). Clinical and molecular analysis in a series of Mexican patients with clinical diagnosis of Fibrodysplasia Ossificans Progressiva (FOP). 9(1). 423–432.

11.

Cruz‐Hernandez, Erick de la, José L. Medina‐Franco, Alma Chávez‐Blanco, et al.. (2015). Ribavirin as a tri-targeted antitumor repositioned drug. Oncology Reports. 33(5). 2384–2392. 39 indexed citations

12.

Pinto, Emília M., Raul C. Ribeiro, Jiang Li, et al.. (2012). An identical, complex TP53 mutation arising independently in two unrelated families with diverse cancer profiles: the complexity of interpreting cancer risk in carriers. Oncogenesis. 1(2). e1–e1. 2 indexed citations

13.

Taja‐Chayeb, Lucía, Aurora González‐Fierro, Catalina Trejo‐Becerril, et al.. (2011). Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype–genotype correlation with the sulfamethazine test. Pharmacogenetics and Genomics. 21(12). 894–901. 12 indexed citations

14.

Candelaria, Myrna, Aurora González‐Fierro, Catalina Trejo‐Becerril, et al.. (2010). Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial. Annals of Hematology. 90(4). 379–387. 57 indexed citations

15.

Piña‐Sánchez, Patricia, Dulce Marı́a Hernández-Hernández, Lucía Taja‐Chayeb, et al.. (2010). Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer. Medical Oncology. 28(4). 1507–1513. 12 indexed citations

16.

Arce-Salinas, Claudia, Blanca Segura-Pacheco, Enrique Bargalló‐Rocha, et al.. (2006). A phase II trial of epigenetic therapy with hydralazine and magnesium valproate associated to doxorubicin and cyclophosphamide for locally advanced breast cancer. Journal of Clinical Oncology. 24(18_suppl). 13147–13147. 1 indexed citations

17.

Chávez‐Blanco, Alma, Blanca Segura-Pacheco, Enrique Pérez‐Cárdenas, et al.. (2005). Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study. Molecular Cancer. 4(1). 22–22. 113 indexed citations

18.

Zambrano, Pilar, Blanca Segura-Pacheco, Enrique Pérez‐Cárdenas, et al.. (2005). A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. BMC Cancer. 5(1). 44–44. 118 indexed citations

19.

Trejo‐Becerril, Catalina, Luis F. Oñate‐Ocaña, Lucía Taja‐Chayeb, et al.. (2005). Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance. BMC Cancer. 5(1). 65–65. 14 indexed citations

20.

Chávez‐Blanco, Alma, Lucía Taja‐Chayeb, Lucely Cetina, et al.. (2002). Neuroendocrine Marker Expression in Cervical Carcinomas of Non-Small Cell Type. International Journal of Gynecological Pathology. 21(4). 368–374. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact